01/06/2026 - Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies
Arizona Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies · January 6, 2026
Arizona Senate ad hoc committee held an informational hearing on access to FDA breakthrough psychedelic mental-health therapies, featuring veterans and clinicians who argued for state preparedness, expanded Right to Try access, and additional funding for clinical trials. Presenters described trial results, clinical safeguards, and barriers from federal scheduling and DEA processes.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.